TACE Combined With Lenvatinib and MWA in the Treatment of Locally Advanced Large Hepatocellular Carcinoma
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
To explore the objective effectiveness and safety of TACE combined with Lenvatinib in the
treatment of advanced liver cancer. After successful down-stage, radical microwave ablation
was further performed.